SecSonar.com

InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

InMed Pharmaceuticals Inc. (INM) is a Biotechnology company based in CA with a market capitalization of $2.9M. Revenue grew 7.5% year-over-year and free cash flow was negative at -$7.8M. This page tracks INM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CA · 13 employees · IPO May 5, 2014

Valuation

Valuation & price

$1.73 · as of May 26, 2026 · -45.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.16

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.86$1.75$0.64Jul 25Dec 25Jul 26Jul 7, 25$2.73Jul 9, 25$2.86Jul 11, 25$2.75Jul 15, 25$2.78Jul 17, 25$2.64Jul 21, 25$2.63Jul 23, 25$2.69Jul 25, 25$2.64Jul 29, 25$2.67Jul 31, 25$2.43Aug 4, 25$2.37Aug 6, 25$2.27Aug 11, 25$2.25Aug 13, 25$2.25Aug 15, 25$2.32Aug 19, 25$2.25Aug 21, 25$2.22Aug 25, 25$2.23Aug 27, 25$2.25Aug 29, 25$2.22Sep 3, 25$2.11Sep 5, 25$2.11Sep 9, 25$2.25Sep 11, 25$2.16Sep 16, 25$2.32Sep 18, 25$2.36Sep 22, 25$2.27Sep 24, 25$2.18Sep 26, 25$2.19Sep 30, 25$2.19Oct 2, 25$2.26Oct 6, 25$2.24Oct 8, 25$2.46Oct 10, 25$2.12Oct 14, 25$2.20Oct 16, 25$2.08Oct 21, 25$2.16Oct 23, 25$2.03Oct 27, 25$2.04Oct 29, 25$1.88Oct 31, 25$1.88Nov 4, 25$1.73Nov 6, 25$1.71Nov 10, 25$1.62Nov 12, 25$1.73Nov 14, 25$1.71Nov 18, 25$1.46Nov 20, 25$1.25Nov 25, 25$1.40Nov 28, 25$1.33Dec 2, 25$1.32Dec 4, 25$1.34Dec 8, 25$1.31Dec 10, 25$1.32Dec 12, 25$1.43Dec 16, 25$1.32Dec 18, 25$1.29Dec 22, 25$1.25Dec 24, 25$1.23Dec 29, 25$1.19Jan 2, 26$1.12Jan 6, 26$1.13Jan 8, 26$1.25Jan 12, 26$1.17Jan 14, 26$1.13Jan 16, 26$1.10Jan 21, 26$1.15Jan 23, 26$1.11Jan 27, 26$1.07Jan 29, 26$1.07Feb 2, 26$1.10Feb 4, 26$1.00Feb 9, 26$0.94Feb 11, 26$0.99Feb 13, 26$0.88Feb 18, 26$0.86Feb 20, 26$0.86Feb 24, 26$0.88Feb 26, 26$0.88Mar 2, 26$0.82Mar 4, 26$0.93Mar 6, 26$0.92Mar 10, 26$0.82Mar 12, 26$0.80Mar 17, 26$0.89Mar 19, 26$0.82Mar 23, 26$0.76Mar 25, 26$0.70Mar 27, 26$0.66Mar 31, 26$0.64Apr 2, 26$0.68Apr 7, 26$0.68Apr 9, 26$0.64Apr 13, 26$0.71Apr 15, 26$0.71Apr 17, 26$0.71Apr 22, 26$0.78Apr 24, 26$0.77Apr 28, 26$0.70Apr 30, 26$0.72May 4, 26$0.75May 6, 26$0.73May 8, 26$0.65May 12, 26$0.66May 14, 26$0.65May 18, 26$0.68May 20, 26$1.61May 22, 26$1.72May 28, 26$1.68Jun 1, 26$1.56Jun 3, 26$1.59Jun 5, 26$1.58Jun 9, 26$1.53Jun 11, 26$1.58Jun 15, 26$1.51Jun 17, 26$1.49Jun 22, 26$1.50Jun 24, 26$1.55Jun 26, 26$1.54Jul 2, 26$1.56
$0.6152-week range$3.17
Loading valuation history…

Fundamentals

Key fundamentals

$2.9M

Market cap

7.5%

Revenue growth (YoY)

34.5%

Gross margin

-$7.8M

Free cash flow (USD)

-$14.1M

Net debt

Net cash position

156.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$1.1MFY 2023$4.1MFY 2024$4.6MFY 2025$4.9M
$0$4.9M

Free cash flow by year

2016 → 2025

FY 2016$-387.0KFY 2017$-2.4MFY 2018$-3.7MFY 2019$-6.7MFY 2020$-7.4MFY 2021$-9.8MFY 2022$-15.6MFY 2023$-7.4MFY 2024$-7.0MFY 2025$-7.8M
-$387K-$7.8M

Gross margin by year

2022 → 2025

FY 202249.9%FY 202333.9%FY 202423.9%FY 202534.5%
49.9%34.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

3

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $10KVivo Opportunity, LLC · 10% Owner · $10.1KJul 2, 2026Filing
  • Insider buyInsider Buy $392KVivo Opportunity, LLC · 10% Owner · $391.6KJun 10, 2026Filing
  • 8-K eventRegained Nasdaq ComplianceJun 10, 2026Filing
  • Insider buyInsider Buy $722KADAR1 Capital Management, LLC · 10% Owner · $721.5KMay 21, 2026Filing
  • 8-K eventPreferred Investment OptionMay 19, 2026Filing
  • 8-K eventMerger AgreementMay 19, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventPreferred Investment Options AmendedApr 27, 2026Filing
  • 8-K eventCommon Shares OfferingApr 3, 2026Filing

Questions

Frequently asked questions

What is InMed Pharmaceuticals Inc.'s market cap?

InMed Pharmaceuticals Inc. (INM) has a market capitalization of $2.9M.

What is INM's P/E ratio?

A meaningful P/E ratio is not available for INM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is INM's price-to-book (P/B) ratio?

INM trades at 0.16 times book value per share.

Are insiders buying INM stock?

Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at InMed Pharmaceuticals Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

ENSC

Ensysce Biosciences, Inc.

$2.6M

ELAB

PMGC Holdings Inc.

$3.4M

AZTR

Azitra, Inc.

$2.3M

ERNA

Ernexa Therapeutics Inc.

$3.4M

VIVS

VivoSim Labs, Inc.

$3.4M

SILO

Silo Pharma, Inc.

$3.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.